Synergy Between Low Dose Metronomic Chemotherapy and the pH-Centered Approach Against Cancer

Low dose metronomic chemotherapy (MC) is becoming a mainstream treatment for cancer in veterinary medicine. Its mechanism of action is anti-angiogenesis by lowering vascular endothelial growth factor (VEGF) and increasing trombospondin-1 (TSP1). It has also been adopted as a compassionate treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Koltai, Tomas, Cardone, Rosa A., Reshkin, Stephan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862380/
https://www.ncbi.nlm.nih.gov/pubmed/31683667
http://dx.doi.org/10.3390/ijms20215438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862380/
https://www.ncbi.nlm.nih.gov/pubmed/31683667
http://dx.doi.org/10.3390/ijms20215438

Ejemplares similares